Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc. | EVP and General Counsel | Common Stock | 57K | $468K | $8.22 | Dec 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIR | Vir Biotechnology, Inc. | Dec 2, 2024 | 1 | -$625 | 4 | Dec 4, 2024 | EVP and General Counsel |
VIR | Vir Biotechnology, Inc. | Nov 6, 2024 | 1 | -$44.5K | 4 | Nov 7, 2024 | EVP and General Counsel |
VIR | Vir Biotechnology, Inc. | Nov 1, 2024 | 2 | -$32.3K | 4 | Nov 5, 2024 | EVP and General Counsel |
VIR | Vir Biotechnology, Inc. | Oct 1, 2024 | 0 | $0 | 3 | Oct 2, 2024 | EVP and General Counsel |